Avacta is a clinical stage oncology drug company and developer of powerful diagnostics based on its innovative, proprietary Affimer® and pre|CISION™ platforms.
Registrars: |
Capita Registrars |
CEO: |
Alastair Smith |
CFO: |
Tony Peter Gardiner |
Non-Executive Director: |
Christina Coughlin, Paul Fry, Trevor Nichols, Mark Goldberg, Shaun Chilton |
Non-Executive Chairman: |
Eliot Forster |
Address: |
Unit 20, Ash Way, Thorp Arch Estate, Wetherby, United Kingdom |
Phone: |
+44 (0)1904 21 7070 |
Fax: |
+44 (0)84 4414 0453 |
Website: |
http://www.avacta.com |
Email: |
|